Transforming Outcomes: Optimizing Survival, Quality of Life & Treatment Strategies in Advanced RCC : Episode 6
Triplet Regimens for First-Line Advanced Renal Cell Carcinoma
Discussion on triplet therapy regimens in advanced RCC and how progressing therapeutic studies can impact its future use.
EP: 1.Overview of Advanced RCC and Diagnosis
EP: 2.First-Line Treatment Strategies in Renal Cell Carcinoma
EP: 3.Limitations in Treatment of Metastatic Renal Cell Carcinoma
EP: 4.CheckMate 9ER Trial Updates
EP: 5.CheckMate 9ER: Quality of Life Data and Treatment Implications in Advanced RCC
Now Viewing
EP: 6.Triplet Regimens for First-Line Advanced Renal Cell Carcinoma
EP: 7.Clinical Considerations and Treatment Sequencing for Patients with Advanced RCC
EP: 8.Evolving Treatment Landscape in Advanced Renal Cell Carcinoma
Recent Videos
Related Content
Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC
March 1st 2024Podcast
In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy.
Listen
Beyond the First-Line: Economides on Advancing Therapies in RCC
February 1st 2024Podcast
In our 4th episode of Emerging Experts, Minas P. Economides, MD, unveils the challenges and opportunities for renal cell carcinoma treatment, focusing on the lack of therapies available in the second-line setting.
Listen
